We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+17.33%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$2.16B
AUM Growth
+$235M
Cap. Flow
+$21.9M
Cap. Flow %
1.01%
Top 10 Hldgs %
37.62%
Holding
102
New
26
Increased
22
Reduced
15
Closed
27

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$157M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$34.1M
3
NVRO
NEVRO CORP.
NVRO
+$28.6M
4
GILD icon
Gilead Sciences
GILD
+$28.1M
5
PEN icon
Penumbra
PEN
+$26.9M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$92.8M
2
MCK icon
McKesson
MCK
+$50.5M
3
CAH icon
Cardinal Health
CAH
+$45.2M
4
LH icon
Labcorp
LH
+$30.8M
5
BAX icon
Baxter International
BAX
+$25.4M

Sector Composition

Rank Sector Weight
1 Healthcare 67.91%
2 Technology 4.93%
3 Consumer Discretionary 1.42%
4 Industrials 0.78%
5 Utilities 0.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHRS icon
76
Coherus Oncology
CHRS
$196M
– –
-411,727
Closed -$7.35M
DGX icon
77
Quest Diagnostics
DGX
$26.3B
– –
-88,933
Closed -$10.1M
EXAS
78
DELISTED
Exact Sciences
EXAS
– –
-161,679
Closed -$14.1M
FXI icon
79
PUT
iShares China Large-Cap ETF
FXI
$4.31B
– –
-663,200
Closed -$26.3M
HALO icon
80
Halozyme
HALO
$12.2B
– –
-597,545
Closed -$16M
HCA icon
81
CALL
HCA Healthcare
HCA
$89.5B
– –
-179,600
Closed -$17.4M
ICUI icon
82
CALL
ICU Medical
ICUI
$4.61B
– –
-107,200
Closed -$19.8M
IGMS
83
DELISTED
IGM Biosciences
IGMS
– –
-115,988
Closed -$8.47M
IMVT icon
84
Immunovant
IMVT
$8.25B
– –
-67,163
Closed -$1.64M
IWM icon
85
CALL
iShares Russell 2000 ETF
IWM
$83B
– –
-85,200
Closed -$12.2M
JNJ icon
86
Johnson & Johnson
JNJ
$625B
– –
-77,167
Closed -$10.9M
MCK icon
87
McKesson
MCK
$101B
– –
-329,175
Closed -$50.5M
PCRX icon
88
PUT
Pacira BioSciences
PCRX
$997M
– –
-60,000
Closed -$3.15M
TEVA icon
89
Teva Pharmaceuticals
TEVA
$41.2B
– –
-2,034,296
Closed -$25.1M
UNH icon
90
UnitedHealth
UNH
$370B
– –
-55,910
Closed -$16.5M
VRTX icon
91
Vertex Pharmaceuticals
VRTX
$126B
– –
-59,035
Closed -$17.1M
XLF icon
92
CALL
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
– –
-433,600
Closed -$10M
XLI icon
93
CALL
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
– –
-136,100
Closed -$9.35M
ZBH icon
94
Zimmer Biomet
ZBH
$18.4B
– –
-185,288
Closed -$21.5M
DCPH
95
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-250,133
Closed -$14.9M
ARNA
96
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-261,808
Closed -$16.5M
IMMU
97
CALL
DELISTED
Immunomedics Inc
IMMU
– –
-360,000
Closed -$12.8M
MNTA
98
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
– –
-579,994
Closed -$19.3M
1 2 3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q3 2020 Portfolio in Review

As of Q3 2020, PFM Health Sciences held 102 positions worth $2.16B, up 12% from $1.93B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PFM Health Sciences's Q3 2020 filing shows 26 new, 22 increased, 15 reduced and 27 closed positions. Its largest new stake was Outset Medical: 191,533 shares worth $131M. The largest sale was Immunomedics Inc, an estimated $92.8M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 67% a quarter earlier, followed by Technology and Consumer Discretionary.

  • PFM Health Sciences's largest Q3 2020 buy was Outset Medical: 191,533 shares worth $131M.
  • PFM Health Sciences added most to NEVRO CORP. in Q3 2020, an estimated $28.6M increase.
  • PFM Health Sciences's biggest Q3 2020 reduction was Immunomedics Inc, cutting an estimated $92.8M.
  • PFM Health Sciences fully exited McKesson in Q3 2020, selling an estimated $50.5M.
  • PFM Health Sciences's ten largest holdings make up 38% of its $2.16B portfolio in Q3 2020.
  • PFM Health Sciences opened 26 new positions and closed 27 in Q3 2020.
  • PFM Health Sciences's portfolio value rose 12% quarter-over-quarter to $2.16B.

Based on PFM Health Sciences's 13F filing for Q3 2020, filed 16 Nov 2020.